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Improving Health Outcomes and Reintegration for
Reentering Offenders
Healthcare Reform and
Coordinated Care Through
Targeted Holistic Services
Jessica Huening
Jessica.huening@student.shu.edu
Corrections in the United
States is characterized by high rates of
recidivism and an enormous amount of
spending. Nearly 95% of those incarcerated will reenter back into society;
however, the vast majority of released
individuals continue to cycle through
the legal system throughout most of
their lives.1 A staggering $75 billion
dollars was spent in 2008 among federal, state, and local governments, with
the majority of that money used directly
for incarceration costs.2
A complex set of individual
and environmental factors impacts the
health status of the offending population.3 A lack of preventative care, a
lack of coordinated and consistent care,
and the effects of repeated and/or sustained periods of incarceration further
complicates these factors. While returning offenders are heavy consumers
of healthcare services, treatment for
their health conditions declines after
reentering the community.4 Emergency
room visits and hospitalizations provide
the primary source of care for the offending population.5 The result is ultimately individuals reentering into the
community receive acute, fragmented
care for chronic problems.6
Reentering into the community is often an extremely confusing and
stressful period of time fraught with
new challenges. Most individuals entering and leaving prisons come from, and
are returned to, poor minority communities.7 After being removed from their
community for a substantial period of
time, reentering offenders are suddenly

confronted with the need to obtain what
is necessary in order to survive and function: housing, employment, healthcare,
and other services.8 This is often in addition to managing significant health problems such as substance use and mental
health disorders.9
Most returning offenders have
limited to no savings, no immediate access to unemployment benefits, and no
job prospects.10 Additionally, up to 90%
of individuals who are incarcerated at
local and county jails have no insurance
of any kind.11 Ex-offenders face serious
challenges finding a job in an increasingly
competitive job market both due to their
disclosed ex-offender status and general
decreased lack of skills and experience.
Indeed, up to 60% of individuals continue to be unemployed at a legitimate job
one year after their release.12
It is no surprise that the time
immediately following release is a critical
period with a significantly increased risk
of morbidity. In a Washington state
study conducted from 1999-2003, the
risk of death among former inmates during their first two weeks of release was
found to be 12.7 % higher than among
other state residents of the same age,
race, and sex.13 There is also a considerably higher prevalence of cardiovascular
disease, cancer, liver disease, suicide,
homicide, HIV, diabetes, and overdose
among individuals released from prison
than their incarcerated counterparts.14 A
lack of health insurance, difficulty obtaining care, the high prevalence of mental
illness, and the detrimental psychological
stress of reentry contributes to these
problems.15
A coordinated holistic approach
to care is most appropriate given the array of problems the offending population
faces, and the dynamic relationship be

Figure 1: Factors Contributing to
Justice-Involvement
Matthew Epperson, Nancy Wolff, Robert Morgan,
William Fisher, B. Christopher Freuh & Jessica
Huening. The Next Generation of Behavioral Health and
Criminal Justice Interventions: Improving Outcomes by Improving Intervention, Center for Behavioral Health
Services and Criminal Justice Research (2011).

tween health outcomes and criminal
activity. Health problems influence
reentry outcomes including housing,
employment, family relationships, substance use, and recidivism.16 Additionally, many predictors of poor health outcomes are also predictors for criminal
activity.17 Health care needs to be addressed in the reentry planning process,
with a focus on continuity of care and
linkages to appropriate services. 18
Healthcare reform embraces a
holistic approach to healthcare in several ways as legislated in the Patient Protection and Affordable Care Act
(PPACA) signed into law by President
Obama on March 23, 2010. Community health workers will encourage preventative health through education, guidance, and outreach in medically underserved racial and ethnic minority communities.19 Information will be provided
regarding the promotion of healthy be-
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haviors, discouragement of risky health
behaviors, guidance on enrolling in an
applicable health plan, as well as referrals to community based programs that
minimize fragmented care.20 The Secretary of Health and Human Services is
also responsible for planning and implementing a national outreach and
education campaign to increase public
awareness of health across the lifespan,
such as the provision of information
related to: utilizing health services to
reduce health disparities and mitigate
chronic disease, preventative services,
healthy behaviors and proper nutrition,
the negative effects of smoking and
obesity, disease screening, health promotion, and disease prevention to
healthcare providers participating in
Federal programs.21
Additionally, PPACA dramatically expands Medicaid to include
those individuals under the age of 65 at
or below 133% of the federal poverty
level in 2014.22 This will include a substantial proportion of offenders returning to the community as those with the
fewest financial resources often wind
up in the criminal justice system.23 The
Center for Medicare and Medicaid Innovation will undertake many efforts
to streamline patient care and reduce
expenditures through information
technology and the development of
new patient care models.24 The creation of community based medical
homes and teams will be encouraged
through grant funding. 25 These teams
will assist community members and
small-group practices treating chronic
conditions in managing and coordinating care by connecting individuals to
appropriate services and assisting with
facilitating payments to providers. 26
Starting January 1, 2011,
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PPACA has created a state option for
the establishment of “health homes” for
those on Medicaid with chronic problems.27 Participation in the option is
voluntary, however, matching federal
grants are provided for the planning and
development of the health homes, and
States are reimbursed 90% of the Federal Medical Assistance Percentage for the
first eight fiscal quarters.28 Health homes
provide comprehensive treatment and
care in part through integrating and coordinating services with other specialists
and providers such as clinics, behavioral
health services, and substance abuse
services.29 Medicaid benchmark benefits
have also been revised to include minimum essential coverage to include parity
for mental health and addiction disorder
treatment if care is provided through a
managed care organization.30
To be effective for the offending population, however, education and
coordination of traditional continuous
care is likely to be just the beginning.
To maximize improved health outcomes, the individual and environmental
factors associated with criminality must
be targeted and addressed (See Figure
1).31 Individual factors are unique to the
person and include mental illness, addiction, poverty, and antisocial beliefs and
attitudes.32 Environmental factors are
conditions that increase risk of criminal
justice involvement such as drug culture,
homelessness, unemployment, violence,
and prostitution.33 Stress and trauma
further aggravate the individual and the
environmental factors associated with
criminal behavior, as well as increases
the likelihood that individuals will behave in ways harmful to themselves and
the community.34
Policymakers can no longer
afford to ignore the detrimental conse-

quences of an overinflated prison population, the socioeconomic and racial
disparities to accessing and obtaining
appropriate healthcare, and the impact
of individual and environmental factors
on criminal thinking and behavior. 35
The correctional system in the United
States is overwhelmed by a high number
of offenders. The prison-industrial complex is more likely to be a site of trauma,
rape and violence than a genuine source
of rehabilitation.36 Given the harms it is
likely to impose on prisoners during
their time under incarceration, it is imperative that it contribute to assuring
continuous post-incarceration care.
There is no simple and straightforward solution to providing effective
and affordable healthcare to exoffenders. Healthcare reform provides
states with the framework to adopt holistic diversion and reentry practices in
order to improve health outcomes for
the offending population. The efforts
of recent trends in holistic legislation
will be diminished, however, if the causes and effects of criminal thinking and
behavior are not incorporated into case
management, treatment plans, education
outreach, and assistance provided with
dollars allocated for healthcare spending. If these factors are successfully
addressed then not only will health outcomes have the opportunity to improve,
but so will the costs incurred by the
correctional system through effective
diversion and reduced recidivism. ☼
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Regulating Health
Should regulations on the
publication of recent Avian Flu
research be imposed?
Melissa Rifai
Melissa.rifai@student.shu.edu
Scientific research has long
been a boon to our society. It has
lengthened human life expectancy,
eradicated deadly communicable diseases, and cured people of illnesses that
previously would have been deadly.
Nevertheless, with every scientific discovery comes the potential for misuse.
A transmittable strain of a deadly virus
that falls into the wrong hands could
lead to a pandemic, harming hundreds
of thousands of people. We saw the
misuse of a biological agent on a small
scale with Anthrax in 2001, and recent
studies on the H5N1 virus (commonly
referred to as Avian Flu) elicit the same
fear of misuse, called the “dual-use”
concern.1
Avian Flu is a virus that is
highly contagious among poultry.2
Though it is not usually found in humans, the virus can be transmitted
from infected poultry to humans as a
result of close contact.3 However, even
humans infected with H5N1 do not
generally pose a risk to other uninfected humans.4

Two recent studies, one led by
Yoshihiro Kawaoka and the other by
Ron Fouchier provide a model of the
virus that is transmissible in ferrets.5
The Fouchier paper reports on the
transmissibility of the full H5N1 virus,
while the Kawaoka paper “provides a
method for producing a transmissible
H5N1 reassortant virus.”6 The H5N1
strain used in the research was found to
be highly communicable between mammals, and the ferret is considered the
best available model of the flu virus in
humans.7
The two studies could be replicated to
create a highly transmissible virus that
would pose serious threats to biosecurity.8 For that reason, calls for the studies
to remain unpublished or be redacted
became plentiful.9 On February 17,
2012, the World Health Organization
(WHO) convened an expert meeting to
discuss the issue of what portions of the
studies should be published. Although
they reached the decision that both the
Kawaoka and Fouchier studies should
be published in full, the meeting did not
address the larger question of how to
balance the threat of bioterrorism with
the need for scientific research, and
whether or not publication of medical
research should be regulated.10 It is not
necessary to answer this larger question
at this time.
This article argues that the benefits of publishing this Avian Flu research greatly outweigh the risk of bioterrorism. Disallowing or severely regulating the publication of this research
would be a greater risk to public health
than the threat of bioterrorism. For the
following three reasons this research
should be published in full: (1) studying
the flu virus in ferrets does not dictate
exactly how the flu will manifest in humans; (2) studying and understanding

Avian Flu is important for early detection and prevention of the disease as
well as creating vaccinations, especially if it were to be used as a biological
weapon; and (3) past scientific research that has posed a risk of bioterrorism has been published with no
significant public health detriment.
Influenza Behavior in Ferrets is not
an Exact Replica of Influenza Behavior in Humans
Two main differences in the
manifestation of the Avian Flu exist
between ferrets and humans: its communicability and its severity.11 The
communicability of this strain in ferrets has shown to be much greater
than that in humans, but more research is required to know for sure
whether the strain would be as transmissible in humans as it is in ferrets.12
Because influenza is always mutating,
it is not impossible that the strain
would mutate naturally into the strain
created by these studies.13 Since the
advancement of scientific research is
largely based upon building on previous published research, imposing
strict regulation on its publication
would prevent researchers from being
able to understand how the communi-
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cability of the disease could change
as the virus mutates. To prevent
publication at this stage would be
detrimental to the advancement of
Avian Flu research.
Secondly, the strain of the
virus appears to be less severe in
ferrets than it is in humans.14 The
Centers for Disease Control and
Prevention (CDC) states that 60%
of people infected with the highly
pathogenic form of the virus have
died from the disease.15 However,
only a minority of strains of H5N1
is deadly in ferrets.16 More research
is needed to understand how the
virus will behave in humans and
whether the severity of this strain of
the Avian Flu will mirror the manifestation in ferrets, or be more severe. Although ferrets provide a
viable framework for understanding
how influenza will behave, it is not
an exact model. Preventing or regulating the publication of Avian Flu
research, as some members of the
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scientific community have called for,
would hinder scientists’ ability to answer
the questions of human communicability
and severity, posing a risk to public
health if the virus were to naturally mutate.
We Must be Able to Detect, Contain and
Prevent the Virus Should it become a
Biological Weapon
An outbreak of Avian Flu could
manifest in a number of ways. Should
Kawaoka and Fouchier’s research fall
into the wrong hands, it is important that
the scientific community have information about how to detect, treat, and
vaccinate against the virus. Without published research, we may be unable to find
a way to treat or contain an Avian Flu
pandemic if the flu mutates into a more
communicable strain from human to
human. If such a strain develops and is
spread, whether naturally or through an
act of terror, there will be a large public
health issue at hand.

In 2009, a worldwide outbreak of the H1N1 virus infected an
estimated 61 million people.17 The
virus was highly contagious and
spread quickly, leading the WHO to
declare it a pandemic.18 Following the
outbreak of the virus, the response to
the pandemic was evaluated, concluding that the H1N1 pandemic
“exposed vulnerabilities in public
health capacities, limitations of scientific knowledge…and challenges in
the communications among experts,
policymakers and the public.”19 The
evaluation concludes, “The world is ill
-prepared for a severe influenza pandemic.”20 In order to rectify this, the
WHO makes a number of recommendations including, but not limited to,
“sharing of viruses and access to vaccines,” “expanding influenza vaccine
production capacity,” and taking
“measures to detect and promptly
identify potential pandemic influenza
viruses.”21
In order to accomplish these
goals and be better prepared for an
Avian Flu pandemic, research must be
conducted, and studies must be published and shared among the scientific
community. Prohibiting the Fouchier
and Kawaoka studies from being published in full would create a great risk
to public health, resulting unpreparedness to combat an outbreak of the
virus. The more time and opportunity that the scientific community has to
research and understand the way that
Avian Flu can mutate and spread, the
better prepared it will be to deal with
bioterrorism, or a natural mutation of
the virus.
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Scientific Research that has Posed a Risk
of Bioterrorism has Been Published in
the Past
Advances in medical research
often ignite concerns of misuse, a phenomenon often called the “dual use concern.”22 In the context of Avian Flu, the
dual-use concern is whether the biosecurity risks of publishing the Fouchier and
Kawaoka studies in full outweigh the
benefits of disseminating the research.23
History has shown that publication of
studies that pose a risk of bioterrorism is
possible without the research being misused. For example, a study detailing the
reconstruction of the 1918 influenza
virus was published in full, and the
threat of bioterrorism has not come to
fruition.24 In addition, the results of
extensive research about the smallpox
virus, as well as reserves of the smallpox
virus have been around for almost 30
years and neither the research, nor the
reserves of the virus, has been misused.25
In fact, there have been very
few incidents of misuse of medical research in the United States. One such
incident occurred in 1984 when a religious group used Salmonella typhimurium to contaminate restaurant salad bars
in Oregon.26 The group, running a legitimate clinical laboratory, used books that
described “bacteria and other methods
to make people ill,” and learned to culture the bacteria with the help of a laboratory technician.27 The misuse of the
published results, and the aid from a
member of the scientific community led
to an estimated 751 infections, but there
were no fatalities.28 Considering these
results, it is important to be cautious of
bioterrorism, but the threat is not greater
than that to public health that exists by
not publishing research results, including
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"THE MORE TIME AND OPPORTUNITY THAT THE SCIENTIFIC
COMMUNITY HAS TO RESEARCH
AND UNDERSTAND THE WAY
THAT AVIAN FLU CAN MUTATE
AND SPREAD, THE BETTER PREPARED IT WILL BE TO DEAL WITH
BIOTERRORISM, OR A NATURAL
MUTATION OF THE VIRUS."

those from the recent studies of Avian
Flu.

Conclusion
For the foregoing reasons, the
publication of this Avian Flu research
should not be strictly regulated or prohibited. Though the publication of scientific research often carries the dual-use
concern, there have been relatively few
instances of misuse in comparison to the
vast amount of research that is published.
Because the Kawaoka and
Fouchier studies of Avian Flu in ferrets
are not exact models of how the virus
will behave in humans, and because there
is a need to develop vaccines and ways to
detect the virus if it were to mutate or be
released in an act of bioterrorism, the
threat of bioterrorism does not outweigh
the public health interest in publication
of results. ☼
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Flynn v. Holder: A Slippery Slope Towards Organ Compensation?
By Ryan Upchurch
Ryan.upchurch@student.shu.edu
In April 2010, Kumud Majumder suffered every parent’s worst nightmare when he lost his son and only
child, Arya, to leukemia.1 Arya, whom
Kumud described as “an angel who
transformed my life” was only eleven
years old when he passed.2 His death
was in part hastened by the inability to
find a bone marrow match for transplant. Unfortunately, stories resembling
Kumud’s are far too commonplace.
Over 100,000 Americans are diagnosed
annually with serious blood and bone
marrow disorders, with leukemia being
the most prominent diagnosis.3 Many of
these individuals require a transplant of
bone marrow cells to combat their particular malady.
Difficulty of Bone Marrow Matches
Finding matches for bone marrow recipients is a difficult proposition
because there are various types of proteins present on bone marrow stem
cells. Family members generally offer

the best probability for a match, but
even then the estimated success rate of
30% is paltry at best.4 The difficulty in
matching blood stem cells has led to
striking statistics for those in need. An
estimated 40,500 adults are diagnosed
with leukemia annually as well as another 3,500 children.5 Anywhere between
2,000 and 3,000 Americans die every
year from a failure to achieve a suitable
bone marrow match for their bloodbased illness.6

was described by the Court as a
“painful, unpleasant procedure” in
which thick needles are inserted into the
cavities of the anesthetized donor’s
bones in order to extract the soft, fatty
substance from within commonly
known as bone marrow.12 This procedure for bone marrow donation was in
place in 1984 when Congress enacted
the National Organ Transplant Act
(NOTA), and it accounts for about one
third of current donations.13

Statistics illustrate distinctive
success rates for people of different
racial groups. Matches are rare for
those of mixed-race parentage and African American descent, as they tend to
possess a combination of African, Caucasian, and Native American genes.7
Caucasian patients are successfully
matched roughly 70% of the time, but
this number drops to only about 40%
for Americans of African descent.8 A
potential means of increasing the number of matches is to possibly enlarge the
donor pool by offering some form of
compensation. Until the Flynn v. Holder
decision, this was presumed to be prohibited by the National Organ Transplantation Act (“NOTA”).9

However, the newer method of
apheresis has been developed since
then. For apheresis, the donor is first
injected with granulocyte colonystimulating factor medication for five
days prior to the procedure, which increases the amount of blood stem cells
that exit from the marrow and enter
into the bloodstream.14 Afterwards, a
collection needle is placed into the donor’s vein.15 The apheresis machine separates out the blood stem cells and the
left over fluid is injected back into the
donor. The stem cells taken from the
donor will be replaced naturally by his
or her body within three to six weeks.16
The apheresis method of extraction is
more common now, being used in
about two thirds of all donations.17

Flynn v. Holder: Legalizing Compensation
for the Apheresis Method of Donation
On December 1, 2011, the
Court of Appeals for the Ninth Circuit
held in Flynn v. Holder that compensation
for bone marrow stem cells derived
from the “peripheral blood stem cell
apheresis method” (“apheresis”) was
legal.10 Additionally, the Court confirmed that compensation was still prohibited for donation of bone marrow
through the more antiquated method of
aspiration.11
Whole blood enters the centrifuge (1) and
separates into plasma (2), leukocytes (3),
and erythrocytes (4). Selected components
are then drawn off (5).

The Court considered the distinctions between the two methods of
marrow donation, apheresis and aspiration, in arriving at its ruling. Aspiration

On its face, NOTA prohibits
any compensation for bone marrow.18
However, the Ninth Circuit did not believe that the statute was applicable to
the apheresis method of bone marrow
donation because the Court likened the
apheresis method to an ordinary blood
donation.19 NOTA’s scope specifically
excluded blood and its derivatives.20 As
the Court acknowledged, the only difference between an ordinary blood donation and a donor undergoing the
apheresis method is that the latter involves the donor sitting for longer as
well as the apheresis machine separating
stem cells from the blood.21 When the
apheresis machine is used to sort and
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collect plasma or platelets it is referred to
as a “blood donation” or a “blood plasma
donation.”22 When it is used to separate
out blood stem cells, it is commonly
known as a “bone marrow donation.”23
Apheresis is a “Bone Marrow Donation”
in Name Only
With respect to the newer apheresis method, the question before the
court was whether a procedure commonly referred to as a “bone marrow donation” actually meant that bone marrow
itself was involved. Under the apheresis
method, none of the soft, fatty substance
that is extracted through aspiration is
present.24 Rather, the apheresis machine
merely separates blood stem cells from
the blood that is extracted.25 For the
Court, the critical components were the
actual material separated out and the location from which the material came. The
donor would be providing his or her
blood stem cells, not their bone marrow.
Furthermore, these blood stem cells
would come from the blood, not from
within the cavities of the donor’s bones.
If compensating donors for their stem
cells through this method was banned,
the Court reasoned then that all compensated blood donations must be outlawed
as well. However, the Senate Report had
specifically excluded blood from the language of the statute.26
NOTA provides that “the term
‘human organ’ means the human
(including fetal) kidney, liver, heart, lung,
pancreas, bone marrow, cornea, eye,
bone, and skin or any subpart thereof and
any other human organ (or any subpart
thereof, including that derived from a
fetus) specified by the Secretary of Health
and Human Services by regulation.”27
Subsequently, the government raised the
issue as to whether the blood stem cells
fell under the statutory language of “or
any subpart thereof” in reference to not
just organs in their entirety but any subpart as well.28 These blood stem cells do
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after all originate in the bone marrow
before naturally moving into the bloodstream. Because the distance between
actual bone marrow and the bloodstream is great enough, the Court found
that this argument lacked merit.29 Additionally, the drafters of NOTA could
not have had the apheresis in mind because it had not yet been developed.30

"IN A SMALL BUT HIGHLY SUCCESSFUL STANFORD UNIVERSITY
STUDY, DONORS OF KIDNEYS
THEN PROVIDED THEIR BLOOD
STEM CELLS FOR A BONE MARROW TRANSPLANT TO THE SAME
PATIENT. EIGHT OF THE TWELVE
PATIENTS WERE SUBSEQUENTLY
FREED FROM THEIR NEED FOR
LIFE-LONG IMMUNOSUPPRESSANT MEDICATIONS..."

A Slippery Slope Appears Likely
Perhaps the first thought to
arise from this decision is that of the
proverbial slippery slope. Opponents of
organ commodification may be wary
that the Ninth Circuit’s interpretation
could lead down a path towards black
markets, harvesting of organs, and vast
economic inequalities. On the other
hand, NOTA is explicit in the limitations placed on remuneration for most
body parts. Human kidneys, livers,
hearts, lungs, pancreas and the ever important “any subpart thereof” are just
some of the organs prohibited.31 The
Court’s holding was much narrower
than it may have appeared at first
glance.32 The issue then is whether the
Flynn decision could in any way lead
down a slippery slope towards relaxing
or overruling NOTA in the future.
Generally a slippery slope can
be thought of as a particular decision

(decision A), which may be appealing
now, but increases the probability that
another broader decision (decision B)
will be accepted later.33 Due to its
broader scope, decision B is usually opposed by some who initially wanted A.34
However, many frameworks exist for
different slippery slope arguments, and
often times slippery slopes are composed of more than just two decisions.
A slippery slope made up of three distinct decisions, or points, is a simple
example of a multi-peaked preference
slippery slope.35
The multi-peaked preference
slippery slope provides the most plausible framework for the issue at hand. In
this argument, the middle position is the
least desirable of the three while either
extreme offers a preferable option.36
There are several subsets of multipeaked preference slippery slopes. One
is the basic equality version, in which
both extremes (A & C) are preferred to
the middle position (B) because getting
to position B without then reaching
position C may be unfairly discriminatory.37 In applying this here, position A
represents the way things were prior to
Flynn, position B represents the current
state of affairs legalizing compensation
under apheresis, and position C represents removing the ban on compensation for all organs. The supporters of
position B are happy with the ruling, but
many of them hope to see a move from
position B to position C as well. Position C’s supporters are generally comprised of those afflicted by diseases to
organs within NOTA’s scope. For example, more than 83,000 Americans are
currently on the waiting list for kidneys.38 Roughly 13 of them die every
day.39 It may seem unjust to some that
an individual has a potentially larger
donor pool from which to find a match
based upon the particular part of their
body that is afflicted. Now that position
B has been legalized, if a large enough
percentage of people believe it is unjust
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to not then reach position C, we could
see a slippery slope. Nevertheless, position C might have to eventually be
reached within the legislature given the
broad scope of NOTA in limiting judicial interpretation.
Kidney transplants provide an
interesting scenario to demonstrate the
inequality of not moving from position
B to position C. As is clear from NOTA, the donor offering their kidney cannot be compensated.40 Yet, in an admittedly small but highly successful Stanford University study, donors of kidneys
then provided their blood stem cells for
a bone marrow transplant to the same
patient.41 Eight of the twelve patients
were subsequently freed from their need
for life-long immunosuppressant medications, which are used posttransplantation to prevent the donated
organ from being rejected.42 The immunosuppressant medications are expensive and include severe possible side
effects.43 One estimate places the price
of such medications at anywhere between $2,000 and $4,000 per month,
although insurance or Medicare can be
used to offset some of this cost.44
The donor would still be ineligible for compensation after donating
their kidney. However under Flynn, the
donor could be compensated for their
donated blood stem cells, which then
liberate the recipient from expensive
and often dangerous medications. This
scenario, and the differing likelihoods of
finding a donor match, serves as the
best examples that we may be beginning
down an equality slippery slope towards
some form of organ compensation.
Conclusion
The Flynn decision is a monumental step forward for those afflicted
by diseases of the blood or bone marrow. By legalizing compensation for
donation through apheresis, the chances
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are increased that the donor pool will be
expanded and many more matches can
be made. This is especially true for
mixed race and African American patients whose genetic makeup is more
difficult to match for these kinds of
transplants.
However, it may be premature
to think that this will lead to any immediate change to the statutory construction. NOTA has the same effect it has
had since 1984 and the legislature could
even choose to simply add in “blood
stem cell apheresis” to the statute if it so
desired.45 Perhaps in the near future,
regenerative medicine will alleviate the
need for most organ transplants as patients can have the requisite organ
grown from their own stem cells.46 A
revitalized debate over organ commodification stemming from this decision is
an important step for a slippery slope,
though.
At any rate, Flynn is effectual
and positive change and should be celebrated as such. It is only when Flynn is
assessed in relation to other organs that
it could be dismissed as presently being
too narrow. Successful implementation
of recompense for blood stem cells
could still serve as a case study for those
organs that remain prohibited by NOTA. For now, it may not initially appear
that Flynn will lead to broader compensation, but one often cannot see where a
slippery slope began until one has
reached the bottom. ☼
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